| Application no. and date | 00959213.0 (espacenet) (Federated) (European Patent Register), 20000810 | | Patent/reg. no. and date | DK/EP 1214056, 20031029 | | Publication date | 20020619 | | Priority no. and date | US 155942 P, 19990924 | | EP pub. no. and date |
EP 1214056 20020619 | | Effective date | | | Applicant/owner | Novartis AG,
4002 Basel, CH | | Applicant ref. no. | P20030120 | | Inventor | BHAGAT, Haresh, G., 6437 Elmcrest Court
Fort Worth, TX 76132, US,
SINGH, Onkar, N., 5606 Rachel Court
Arlington, TX 76017, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/57, A61K 9/10 | | Title | Topiske suspensionsformuleringer indeholdende ciprofloxacin og dexamethason | | Int. application no. | US2000021961 | | Int. publication no. | WO2001022936 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
